Just to add to the woes. Maybe the FDA is getting edgey on India/China Approvals???
Another Indian drugmaker faces FDA import ban
The FDA has banned imports from a factory run by Indian drugmaker Aurobindo following an inspection there in December. The ban on products from the company?s Cephalosporin facility near Hyderabad echoes an import ban on Claris Lifesciences in November after fungal contamination of IV medications made in India went unaddressed. Products from several Ranbaxy factories in India are also still under import bans after widespread manufacturing violations three years ago.
In January, Aurobindo sold its active pharmaceutical ingredients (API) division to a Chinese manufacturer, Sinopharm. China?s drug industry has been in the news in recent weeks as Congress opens an investigation into the heparin crisis that three years ago was linked to more than a hundred American deaths.
http://postscript.communitycatalyst.org/?p=2250&utm_source=twitterfeed&utm_medium=twitter
- Forums
- ASX - By Stock
- TSN
- every day
every day, page-12
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online